Levitra vs. Cialis: Vardenafil and Tadalafil Compared
Vardenafil and tadalafil both support erections during sexual stimulation, but they fit different schedules. Vardenafil usually serves an on-demand plan around a particular encounter. Tadalafil offers a longer treatment window and, for eligible patients, a low-dose daily regimen.
Levitra contained vardenafil; Cialis contains tadalafil. Generic versions provide the respective active ingredients. Comparing the names alone misses the decisions that matter: timing, duration, medical eligibility, tolerability, and the cost of the prescribed regimen.
Neither medicine is the best choice for every man. A clinician can use those differences to choose a starting plan, then review the actual response. An unsuccessful attempt with one tablet does not establish that the other will fail, nor does it justify combining them.
The shared mechanism
Both drugs inhibit phosphodiesterase type 5, or PDE5. During arousal, nitric oxide helps produce cGMP, a chemical signal that relaxes smooth muscle and increases blood entering the penis. PDE5 breaks down cGMP. Inhibiting it helps the erection response continue.
Sexual stimulation remains necessary. These medicines do not manufacture desire or create an erection continuously for the whole time the drug remains in the body. They also do not protect against pregnancy or sexually transmitted infections.
ED can involve diabetes, vascular disease, high blood pressure, nerve injury, medication effects, depression, or performance anxiety. Those contributors can overlap. A prescription may help blood flow while counseling, risk-factor treatment, or a medication review addresses another part of the problem.
Differences that affect everyday use
| Question | Vardenafil | Tadalafil |
|---|---|---|
| Usual on-demand starting amount | 10 mg for many adults, subject to individual restrictions. | 10 mg for many adults, subject to individual restrictions. |
| Typical planning | Approximately one hour before sex. | Allow time for onset; some men respond from about 30 minutes, with fuller effect taking longer. |
| Duration | Several hours, with individual variation. | Potential benefit up to 36 hours after an on-demand dose. |
| Low-dose daily ED regimen | No equivalent standard daily ED regimen in conventional labeling. | 2.5 mg daily, with possible increase to 5 mg. |
| Food | A very fatty meal can affect the early concentration peak. | Food does not materially change absorption. |
| Distinct precaution | Long QT syndrome and certain antiarrhythmic medicines. | Longer exposure extends the period in which interactions remain relevant. |
The same milligram starting amount does not make the compounds interchangeable. They have different pharmacokinetics and formulation-specific instructions. A clinician should direct a switch and explain the interval before starting the replacement.
Duration is not the same as half-life
Vardenafil has an average half-life of approximately four to five hours. Tadalafil's average half-life is approximately 17.5 hours. Half-life describes a decline in blood concentration, while duration of erection support describes a clinical response. They are related measures, not interchangeable numbers.
Tadalafil's potential benefit up to 36 hours does not mean an erection lasts 36 hours. Arousal can still trigger and end separate erections within the treatment window. An erection persisting for more than four hours needs emergency care regardless of which drug produced the response.
The longer window can reduce pressure to coordinate a tablet with one encounter. Some patients value that flexibility; others prefer a shorter exposure period. Longer action can also mean a longer period of side effects or interaction concerns.
On-demand and daily tadalafil serve different plans
An on-demand tadalafil prescription commonly begins at 10 mg and may change to 5 mg or 20 mg according to effectiveness and tolerability. A daily ED regimen uses lower amounts, typically 2.5 mg or 5 mg, taken according to the prescription without tying each tablet to sex.
Daily use does not authorize an additional on-demand tablet. Drug exposure accumulates toward a steady state, so adding another PDE5 inhibitor can overlap treatment even when the last daily tablet was not taken immediately before sex.
For urinary symptoms from benign prostatic hyperplasia, tadalafil has an approved 5 mg daily role, including in some men with both ED and BPH. Other tadalafil products treat pulmonary arterial hypertension under a separate regimen. Vardenafil's approved indication is ED; these other uses do not transfer to it.
What trials establish about benefit
Vardenafil has improved erectile function across different ages and ED severities. A 12-week trial included 580 men and found better erectile function scores than placebo across analyzed subgroups. The result supports efficacy without predicting how an individual will respond.
Studies in men with diabetes-related ED also found improvements in penetration and maintenance of erections with vardenafil. Diabetes can make ED harder to treat, but the diagnosis does not automatically rule out oral treatment or establish which PDE5 inhibitor will suit the patient.
For tadalafil, an integrated analysis of five randomized trials included 1,112 men with mild through severe ED. The trials supported improvement in erection-related outcomes compared with placebo. Studies in patients with more severe ED and associated health conditions have also reported benefit.
Different doses, populations, and outcomes make percentages from separate trials unsuitable for declaring a universal winner. A reported improvement in erections, successful penetration, maintenance through intercourse, and satisfaction measure different aspects of the experience.
Preference and satisfaction evidence
The European EDOS observational study enrolled more than 8,000 men who selected treatment in routine care. Its six-month report found benefit with tadalafil, sildenafil, and vardenafil, with tadalafil users reporting higher numerical satisfaction on several measures and less concern about timing.
This was not a randomized comparison assigning otherwise identical patients to each medicine. Treatment choice, discontinuation, switching, and the patients who remained on a single drug can influence the result. The finding helps explain preferences; it cannot guarantee that tadalafil will work better for every man.
A useful follow-up therefore asks about more than firmness. Discuss whether the plan created time pressure, whether adverse effects discouraged use, and whether the dose supported the activities that mattered to the patient and partner.
Premature ejaculation and cardiovascular research need context
Researchers have studied PDE5 inhibitors in men who also report premature ejaculation. Some vardenafil and tadalafil studies suggest improvements in control, satisfaction, or ejaculation timing, especially when ED coexists. These findings do not make either drug an approved general treatment for premature ejaculation.
A 2022 tadalafil study reported follow-up after daily 5 mg treatment in men with both concerns. Such evidence can inform a specialist discussion, but it does not remove the need to distinguish erection difficulty from a primary ejaculation disorder.
Observational research has also associated tadalafil exposure with lower rates of major cardiovascular events and mortality among men with ED. An association cannot establish that tadalafil prevents those events. A patient should not choose it as a substitute for cardiovascular assessment or prescribed prevention treatment.
Common adverse effects
Both medicines can cause headache, flushing, indigestion, nasal congestion, dizziness, and blood pressure symptoms. Tadalafil can also cause back pain or muscle aches. Visual symptoms can occur with PDE5 inhibitors, though their frequency and pattern vary.
Trial tables may show different rates of particular symptoms, but comparing separate studies has limits. The relevant question is whether the individual experiences an acceptable balance at the prescribed dose. A lower amount or another treatment can sometimes improve tolerability.
Seek emergency treatment for an erection lasting more than four hours. Sudden sight loss, sudden hearing loss, chest pain, fainting, severe breathlessness, or signs of a serious allergic reaction also need urgent assessment.
Interactions and cardiovascular eligibility
Neither drug may combine with nitrates, recreational nitrites called poppers, or guanylate cyclase stimulators such as riociguat. These combinations can produce dangerous blood pressure reductions. A lower dose does not make them acceptable.
Alpha-blockers and other antihypertensive medicines require individualized review. They are not all absolute prohibitions, and a clinician can sometimes construct a supervised plan. Do not stop a cardiovascular or prostate prescription independently to accommodate an ED medicine.
Strong inhibitors of CYP3A4 can raise exposure. Some antifungals, antibiotics, HIV treatments, and other medicines belong in that review. Grapefruit may also affect metabolism. Larger amounts of alcohol can worsen dizziness and erectile function.
With tadalafil, the longer exposure period remains relevant if an emergency clinician considers nitrate treatment. The labeling describes at least 48 hours before considering nitrates in a life-threatening situation, and only with close medical supervision. That is not permission for a patient to self-administer a nitrate after waiting.
Vardenafil carries a separate QT precaution. People with congenital long QT syndrome or those taking class IA or III antiarrhythmics should avoid it. The clinician also needs to assess recent cardiovascular events, unstable symptoms, and whether sex itself is advisable.
Comparing costs without comparing different prescriptions
Generic availability, strength, quantity, pharmacy, insurance, and discount terms all affect cost. Do not assume that an old online price remains available or that a brand-versus-generic comparison reflects the same dose and dispensing terms.
For a daily regimen, compare likely monthly spending. For on-demand treatment, compare the cost per prescribed use and the quantity you realistically expect to need. Include consultation, delivery, and renewal charges if they apply.
The FDA determined that discontinued U.S. Levitra strengths had not left the market for reasons of safety or effectiveness. Generic vardenafil remains the relevant option to discuss with a dispensing pharmacy. Current local supply still needs confirmation.
How to make a treatment trial useful
Keep a brief record of timing, meals, alcohol, stimulation, erection quality, and adverse effects. Describe whether the problem involves achieving firmness, maintaining it, or another part of sexual function. This gives the clinician a basis for adjustment beyond a simple preference for one brand.
If a medicine fails despite appropriate use, discuss another oral option or a vacuum device, counseling, alprostadil, or specialist treatment. Ask for explicit replacement instructions so the old and new medicines do not overlap unintentionally.
Health factors that can change the apparent choice
Kidney and liver function affect eligibility and dosing. Tadalafil's longer exposure can become more relevant when clearance is impaired, and some regimens require restrictions in renal disease. Vardenafil also has restrictions with severe liver impairment and renal dialysis. These details can outweigh a preference for a particular duration.
Previous priapism, blood cell disorders, penile fibrosis, or Peyronie's disease can change the discussion of prolonged erections. A history of NAION or unexplained sight loss warrants review before another PDE5 inhibitor. Choosing a different brand does not remove a shared precaution.
Formulation matters as well. A dissolving vardenafil tablet does not automatically substitute for a conventional tablet at the same nominal amount. A compounded preparation can also have different ingredients or instructions from the approved product used in a trial.
Bring the actual package to a review if the product or label seems unclear. The clinician needs to know what you received, how you took it, and what happened before deciding whether the molecule, dose, schedule, or another contributor explains the experience.
Ask how the proposed choice fits the activities you want to resume. The answer may concern less timing pressure, fewer adverse effects, a urinary symptom indication, or an interaction that excludes one option. Recording that goal makes the next review more useful than simply asking whether a tablet worked.
Neither medicine corrects testosterone deficiency or establishes why desire has changed. If low libido, fatigue, or another hormonal symptom accompanies ED, describe it separately so the clinician can decide whether additional assessment belongs in the plan.
Sources
- DailyMed: vardenafil prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31be68b0-ac7e-42d0-9435-1f0a329b63d8
- MedlinePlus: vardenafil. https://medlineplus.gov/druginfo/meds/a603035.html
- DailyMed: tadalafil prescribing information. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78509a43-a907-4359-9022-f38c4f765880
- Porst and colleagues: vardenafil patient subgroups. https://pubmed.ncbi.nlm.nih.gov/12946758/
- Brock and colleagues: integrated tadalafil trial analysis. https://pubmed.ncbi.nlm.nih.gov/12352386/
- Martin-Morales and colleagues: EDOS satisfaction study. https://pubmed.ncbi.nlm.nih.gov/17084518/
- Gharib and colleagues: tadalafil follow-up in men with ED and premature ejaculation. https://pmc.ncbi.nlm.nih.gov/articles/PMC8881064/
- Kloner and colleagues: observational cardiovascular outcomes. https://pmc.ncbi.nlm.nih.gov/articles/PMC10878497/
Related reading
- Levitra vs. Viagra: Vardenafil and Sildenafil Compared
- Sildenafil: Uses, Timing, Safety and Treatment Options
- Is Sildenafil Safe? Health Conditions, Interactions and Precautions
- Sildenafil and Viagra Side Effects: What to Expect and When to Act
- Sildenafil Interactions: Medicines, Food and Alcohol
- Erectile dysfunction treatment options
Medical Disclaimer: This content is provided for informational and educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. Always consult a qualified physician or licensed healthcare provider with any questions regarding a medical condition or prescription medication. Read our Editorial & Medical Review Policy.
